Operating Lease, Right-of-Use Asset of Monte Rosa Therapeutics, Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Monte Rosa Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • Monte Rosa Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $25,065,000, a 8.4% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Monte Rosa Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $25,065,000 -$2,299,000 -8.4% 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $25,674,000 -$2,219,000 -8% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $26,263,000 -$2,159,000 -7.6% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $26,831,000 -$1,977,000 -6.9% 31 Dec 2024 10-Q 06 Nov 2025 2025 Q3
Q3 2024 $27,364,000 -$2,044,000 -7% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $27,893,000 -$2,466,000 -8.1% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 $28,422,000 -$2,112,000 -6.9% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $28,808,000 -$6,024,000 -17% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $29,408,000 -$9,126,000 -24% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $30,359,000 -$16,743,000 -36% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $30,534,000 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $34,832,000 +$34,832,000 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $38,534,000 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $47,102,000 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q4 2021 $0 31 Dec 2021 10-K 16 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.